1. Home
  2. TFSL vs FOLD Comparison

TFSL vs FOLD Comparison

Compare TFSL & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFSL
  • FOLD
  • Stock Information
  • Founded
  • TFSL 1938
  • FOLD 2002
  • Country
  • TFSL United States
  • FOLD United States
  • Employees
  • TFSL N/A
  • FOLD N/A
  • Industry
  • TFSL Savings Institutions
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • TFSL Finance
  • FOLD Health Care
  • Exchange
  • TFSL Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • TFSL 3.3B
  • FOLD 2.9B
  • IPO Year
  • TFSL 2007
  • FOLD 2007
  • Fundamental
  • Price
  • TFSL $13.21
  • FOLD $6.10
  • Analyst Decision
  • TFSL Hold
  • FOLD Buy
  • Analyst Count
  • TFSL 1
  • FOLD 10
  • Target Price
  • TFSL $15.00
  • FOLD $16.22
  • AVG Volume (30 Days)
  • TFSL 263.2K
  • FOLD 5.3M
  • Earning Date
  • TFSL 07-29-2025
  • FOLD 05-01-2025
  • Dividend Yield
  • TFSL 8.55%
  • FOLD N/A
  • EPS Growth
  • TFSL 0.98
  • FOLD N/A
  • EPS
  • TFSL 0.28
  • FOLD N/A
  • Revenue
  • TFSL $304,101,000.00
  • FOLD $543,141,000.00
  • Revenue This Year
  • TFSL $0.93
  • FOLD $19.85
  • Revenue Next Year
  • TFSL $4.05
  • FOLD $23.50
  • P/E Ratio
  • TFSL $47.17
  • FOLD N/A
  • Revenue Growth
  • TFSL 0.00
  • FOLD 28.25
  • 52 Week Low
  • TFSL $11.29
  • FOLD $5.81
  • 52 Week High
  • TFSL $15.00
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • TFSL 52.32
  • FOLD 39.70
  • Support Level
  • TFSL $13.00
  • FOLD $6.05
  • Resistance Level
  • TFSL $13.37
  • FOLD $6.37
  • Average True Range (ATR)
  • TFSL 0.17
  • FOLD 0.24
  • MACD
  • TFSL -0.06
  • FOLD 0.04
  • Stochastic Oscillator
  • TFSL 28.77
  • FOLD 33.51

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: